Navigation Links
Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
Date:11/29/2007

cs and clinical benefit has not been established.

Safety Assessment

The majority of adverse events reported in this study were mild to moderate in severity. The most frequently reported adverse events for VYVANSE were insomnia (8 percent), decreased appetite (6 percent), anorexia (4 percent) and upper respiratory tract infection (2 percent); for Adderall XR they were decreased appetite (4 percent), upper abdominal pain (4 percent), insomnia (2 percent), upper respiratory tract infection (2 percent) and vomiting (2 percent).

VYVANSE is currently approved in the United States for the treatment of ADHD in children aged 6 to 12 years.

Additional information about VYVANSE and Full Prescribing Information are available at http://www.vyvanse.com.

About ADHD

Approximately 7.8 percent of all school-age children, or about 4.4 million U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and Prevention (CDC). ADHD is one of the most common psychiatric disorders in children and adolescents. The disorder is also estimated to affect 8.1 percent of adults, or approximately 9.2 million adults across the U.S. based on a retrospective survey of adults aged 18 to 44, projected to the full U.S. adult population. ADHD is a neurobiological disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. To be properly diagnosed with ADHD, a child needs to demonstrate at least six of nine symptoms of inattention; and/or at least six of nine symptoms of hyperactivity/impulsivity; the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and home); that the symptoms continue for at least six
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
3. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 A study using ... offered a new look at the composition of carotid ... physicians understand and treat the disease, a leading cause ... Baptist Health Lexington between September 2010 and May 2012, ... Journal of the American College of Cardiology (JACC) ...
(Date:9/30/2014)... 30, 2014 The Chinese wound care market ... rise in the incidence of lifestyle diseases, coupled with ... affordability of better quality of wound care products provide ... coverage of public health insurance schemes and increased reimbursement ... Based on the findings of primary and secondary researches, ...
(Date:9/30/2014)... , Sept. 30, 2014 Valeant Pharmaceuticals International, ... today announced that the company,s Bridgewater, New ... the U.S. Food and Drug Administration (FDA) relating to ... with regards to Sculptra Aesthetic injectable, which was divested ... to the management of Valeant,s contract manufacturers (rather than ...
Breaking Medicine Technology:New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2China Wound Care Market 2China Wound Care Market 3Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... (Nasdaq: ARAY ), the premier radiation oncology ... present at the Oppenheimer Healthcare Conference in New York ... EST/10:00 a.m. PST.  A live webcast ... Investor Relations page of the Company,s website at ...
... Foundation for Infectious Diseases (NFID) joins the Centers for ... of influenza prevention during National Influenza Vaccination Week, December ... holiday season and beyond. Influenza vaccination rates ... years, but many parents remain unaware that annual vaccination ...
Cached Medicine Technology:National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4
(Date:9/30/2014)... Antonio, TX (PRWEB) September 30, 2014 ... September, the Editorial Board of Living with a ... that sheds light on hematological disorders as disabling conditions. ... SSA requires more than a diagnosis to establish a ... cell, chronic thrombocytomenia, myelofibrosis, hereditary telangiectasia, coagulation defects, polycythemia ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Catalent ... of advanced delivery technologies and development solutions for ... a full agenda for the 25th Annual CPhI ... from October 6th to 9th. , Catalent is ... capability expansions during the show, including its facilities ...
(Date:9/30/2014)... Jiwa Law Corporation, a personal injury law ... now be offering free consultation for personal injury claims of ... firm for the first time to meet the Vancouver ICBC ... opportunity to understand what their rights are. The experts at ... to explain to them what the law firm can do ...
(Date:9/30/2014)... California (PRWEB) September 30, 2014 ... its first “crowdfunding” campaign through GoFundMe. The campaign, which ... was for a portion of the funds necessary to ... bus for the Stockton Unified School District (SUSD). The ... will provide a portion of the funds necessary for ...
(Date:9/30/2014)... Coast Dental and Orthodontics is ... practice, located at 1010 Shaw Avenue in Clovis, CA. ... services , and specialty dental care including orthodontics, endodontics, ... and convenient dental care, our Clovis dentists also strive ... Coast Dental at 559-777-6113 to schedule an appointment. , ...
Breaking Medicine News(10 mins):Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:Jiwa Law Corporation Now Offers Personal Injury Consultation Without Any Charge 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3
... WHO has revealed that Africa's TB crisis has its origin ... of the two million people who die from TB every ... nurse at the African Medical and Research Foundation (AMREF) clinic ... who succumbed to TB were also infected with HIV. According ...
... study conducted by Columbia University Medical Center has ... in osteoarthritis, could be effective// in the treatment ... drug treatment with Cox-2 inhibitors or surgery was ... chronic shoulder pain. ,Approximately 1.5 million ...
... to World Health Organization (WHO), two fresh cases of ... from Mudug region//, in southern Somalia and northeastern Somalia ... to neighbouring countries. ,The cases also threaten ... the outbreak which has affected a total of 199 ...
... shoulder pain were left with only two options previously, either ... the safety concerns surrounding Vioxx and other Cox-2 inhibitors were ... has found that sodium hyaluronate, a drug approved by FDA ... for treating the shoulder pain. ,The study was ...
... Transesophageal echocardiography (TEE) is a recent progress in echocardiography ... procedure entails the insertion of a // probe into ... off the heart and help in enabling a motion ... echocardiogram. , ,These detailed images are capable of ...
... and Drug Administration (FDA) approved asthma Flovent HFA for kids ... a reformulation of Flovent that uses the more environmentally friendly ... the canister. ,It is an inhaled corticosteroid that ... , The medication initially was approved by the FDA ...
Cached Medicine News:Health News:Sodium Hyaluronate Shows Promise In Treatment Of Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 3
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range....
... and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal ... 20-200 ... 1.0~2.0 Imprecision(%) ... 1 Dimensions: ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: